121 related articles for article (PubMed ID: 1433209)
1. Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore.
Ward JS; Merritt L; Klimkowski VJ; Lamb ML; Mitch CH; Bymaster FP; Sawyer B; Shannon HE; Olesen PH; Honoré T
J Med Chem; 1992 Oct; 35(22):4011-9. PubMed ID: 1433209
[TBL] [Abstract][Full Text] [Related]
2. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines .
Sauerberg P; Olesen PH; Nielsen S; Treppendahl S; Sheardown MJ; Honoré T; Mitch CH; Ward JS; Pike AJ; Bymaster FP
J Med Chem; 1992 Jun; 35(12):2274-83. PubMed ID: 1613751
[TBL] [Abstract][Full Text] [Related]
3. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
[TBL] [Abstract][Full Text] [Related]
5. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
[TBL] [Abstract][Full Text] [Related]
6. Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.
Ward JS; Merritt L; Calligaro DO; Bymaster FP; Shannon HE; Sawyer BD; Mitch CH; Deeter JB; Peters SC; Sheardown MJ; Olesen PH; Swedberg MD; Sauerberg P
J Med Chem; 1995 Sep; 38(18):3469-81. PubMed ID: 7658434
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and muscarinic activity of quinuclidinyl- and (1-azanorbornyl)pyrazine derivatives.
Street LJ; Baker R; Book T; Reeve AJ; Saunders J; Willson T; Marwood RS; Patel S; Freedman SB
J Med Chem; 1992 Jan; 35(2):295-305. PubMed ID: 1732546
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.
Sauerberg P; Kindtler JW; Nielsen L; Sheardown MJ; Honoré T
J Med Chem; 1991 Feb; 34(2):687-92. PubMed ID: 1995893
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
Arnt J; Lembøl HL; Meier E; Pedersen H
Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
Dunbar PG; Durant GJ; Rho T; Ojo B; Huzl JJ; Smith DA; el-Assadi AA; Sbeih S; Ngur DO; Periyasamy S
J Med Chem; 1994 Aug; 37(17):2774-82. PubMed ID: 8064804
[TBL] [Abstract][Full Text] [Related]
12. The design and pharmacology of novel selective muscarinic agonists and antagonists.
Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
Bymaster FP; Wong DT; Mitch CH; Ward JS; Calligaro DO; Schoepp DD; Shannon HE; Sheardown MJ; Olesen PH; Suzdak PD; Swedberg MD; Sauerberg P
J Pharmacol Exp Ther; 1994 Apr; 269(1):282-9. PubMed ID: 7909558
[TBL] [Abstract][Full Text] [Related]
14. Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation.
Sauerberg P; Jeppesen L; Olesen PH; Sheardown MJ; Fink-Jensen A; Rasmussen T; Rimvall K; Shannon HE; Bymaster FP; DeLapp NW; Calligaro DO; Ward JS; Whitesitt CA; Thomsen C
Bioorg Med Chem Lett; 1998 Oct; 8(20):2897-902. PubMed ID: 9873644
[TBL] [Abstract][Full Text] [Related]
15. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
[TBL] [Abstract][Full Text] [Related]
16. Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney.
Eltze M; Ullrich B; Mutschler E; Moser U; Bungardt E; Friebe T; Gubitz C; Tacke R; Lambrecht G
Eur J Pharmacol; 1993 Jul; 238(2-3):343-55. PubMed ID: 8405103
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists.
Tecle H; Lauffer DJ; Mirzadegan T; Moos WH; Moreland DW; Pavia MR; Schwarz RD; Davis RE
Life Sci; 1993; 52(5-6):505-11. PubMed ID: 8382765
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogs.
Sauerberg P; Olesen PH; Sheardown MJ; Suzdak PD; Shannon HE; Bymaster FP; Calligaro DO; Mitch CH; Ward JS; Swedberg MD
Life Sci; 1995; 56(11-12):807-14. PubMed ID: 10188779
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the interaction of zamifenacin at muscarinic receptors in vitro.
Watson N; Reddy H; Stefanich E; Eglen RM
Eur J Pharmacol; 1995 Oct; 285(2):135-42. PubMed ID: 8566131
[TBL] [Abstract][Full Text] [Related]
20. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E
Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
